Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 95Myelodysplastic Syndromes 26Recurrence 25Lymphoma, Non-Hodgkin 24Neoplasms 21Leukemia, Lymphocytic, Chronic, B-Cell 19Lymphoma, Large B-Cell, Diffuse 15Leukemia 12Lymphoma, Follicular 10Multiple Myeloma 9Hematologic Neoplasms 9Lymphoma, B-Cell, Marginal Zone 8Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell 6Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 4Myeloproliferative Disorders 4Leukemia, Biphenotypic, Acute 4Small Cell Lung Carcinoma 3Prostatic Neoplasms 3GATA2 Deficiency 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Primary Myelofibrosis 2Immunoglobulin Light-chain Amyloidosis 2Colorectal Neoplasms 2

Interventions

venetoclax 1spartalizumab 1sabatolimab 1lintuzumab 1fludarabine 1Sertraline 1Melphalan 1Lenalidomide 1Decitabine 1Biopsy 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Preleukemia × venetoclax × Clear all
NCT06501196 2025-09-24

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

BlossomHill Therapeutics

Phase 1 Recruiting
170 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Preleukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡